{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:25:52Z","timestamp":1794097552914,"version":"4.8.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00266-026-05990-1","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:30:46Z","timestamp":1783445446000},"page":"7703-7731","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Computational Trial of Prophylactic Biostimulator Interventions to Mitigate Facial Sagging Associated With GLP-1 Receptor Agonist Induced Weight Loss"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8443-8338","authenticated-orcid":false,"given":"Eqram","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Michon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parinitha","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golam","family":"Saklayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munim","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woffles T. L.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Richard","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"11","key":"5990_CR1","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/nejmoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. New England J Med. 2021;384(11):989\u20131002. https:\/\/doi.org\/10.1056\/nejmoa2032183.","journal-title":"New England J Med"},{"issue":"3","key":"5990_CR2","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.ajcnut.2023.04.017","volume":"118","author":"Y Liu","year":"2023","unstructured":"Liu Y, Ruan B, Jiang H, Le S, Liu Y, Ao X, et al. The weight-loss effect of GLP-1RAs glucagon-like peptide-1 receptor agonists in non-diabetic individuals with overweight or obesity: a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials. Am J Clin Nutr. 2023;118(3):614\u201326. https:\/\/doi.org\/10.1016\/j.ajcnut.2023.04.017.","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"5990_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/medicines9090047","volume":"9","author":"Y Ozeki","year":"2022","unstructured":"Ozeki Y, Masaki T, Kamata A, Miyamoto S, Yoshida Y, Okamoto M, et al. The effectiveness of GLP-1 receptor agonist semaglutide on body composition in elderly obese diabetic patients: a pilot study. Medicines. 2022;9(9):47. https:\/\/doi.org\/10.3390\/medicines9090047.","journal-title":"Medicines"},{"key":"5990_CR4","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.biopha.2018.08.088","volume":"108","author":"D Sharma","year":"2018","unstructured":"Sharma D, Verma S, Vaidya S, Kalia K, Tiwari V. Recent updates on GLP-1 agonists: current advancements & challenges. Biomed Pharmacother. 2018;108:952\u201362. https:\/\/doi.org\/10.1016\/j.biopha.2018.08.088.","journal-title":"Biomed Pharmacother"},{"key":"5990_CR5","doi-asserted-by":"publisher","DOI":"10.1055\/b-006-160989","volume-title":"Facial Topography","author":"J Pessa","year":"2012","unstructured":"Pessa J, Rohrich R. Facial topography. Georg Thieme Verlag; 2012. https:\/\/doi.org\/10.1055\/b-006-160989."},{"issue":"7","key":"5990_CR6","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1097\/01.prs.0000265403.66886.54","volume":"119","author":"RJ Rohrich","year":"2007","unstructured":"Rohrich RJ, Pessa JE. The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg. 2007;119(7):2219\u201327. https:\/\/doi.org\/10.1097\/01.prs.0000265403.66886.54.","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"5990_CR7","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/PRS.0000000000006181","volume":"144","author":"JM Stuzin","year":"2019","unstructured":"Stuzin JM, Rohrich RJ, Dayan E. The facial fat compartments revisited: clinical relevance to subcutaneous dissection and facial deflation in face lifting. Plast Reconstr Surg. 2019;144(5):1070\u20138. https:\/\/doi.org\/10.1097\/PRS.0000000000006181.","journal-title":"Plast Reconstr Surg"},{"issue":"1-2","key":"5990_CR8","doi-asserted-by":"publisher","first-page":"38S","DOI":"10.1097\/PRS.0000000000007624","volume":"147","author":"RJ Rohrich","year":"2021","unstructured":"Rohrich RJ, Avashia YJ, Savetsky IL. Prediction of facial aging using the facial fat compartments. Plast Reconstr Surg. 2021;147(1\u20132):38S-42S. https:\/\/doi.org\/10.1097\/PRS.0000000000007624.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"5990_CR9","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1097\/GOX.0b013e31828ed1da","volume":"1","author":"JP Farkas","year":"2013","unstructured":"Farkas JP, Pessa JE, Hubbard B, Rohrich RJ. The science and theory behind facial aging. Plast Reconstr Surg - Global Open. 2013;1(1):e8\u201315. https:\/\/doi.org\/10.1097\/GOX.0b013e31828ed1da.","journal-title":"Plast Reconstr Surg - Global Open"},{"issue":"7","key":"5990_CR10","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/DSS.0000000000000505","volume":"42","author":"TC Keaney","year":"2016","unstructured":"Keaney TC. Aging in the male face: intrinsic and extrinsic factors. Dermatol Surg. 2016;42(7):797\u2013803. https:\/\/doi.org\/10.1097\/DSS.0000000000000505.","journal-title":"Dermatol Surg"},{"issue":"12","key":"5990_CR11","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1046\/j.1524-4725.2000.00270.x","volume":"26","author":"LM Donofrio","year":"2000","unstructured":"Donofrio LM. Fat distribution: a morphologic study of the aging face. Dermatol Surg. 2000;26(12):1107\u201312. https:\/\/doi.org\/10.1046\/j.1524-4725.2000.00270.x.","journal-title":"Dermatol Surg"},{"issue":"1","key":"5990_CR12","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.asj.2005.09.0121","volume":"26","author":"SR Coleman","year":"2006","unstructured":"Coleman SR, Grover R. The anatomy of the aging face: volume loss and changes in 3-dimensional topography. Aesthet Surg J. 2006;26(1):S4\u20139. https:\/\/doi.org\/10.1016\/j.asj.2005.09.0121.","journal-title":"Aesthet Surg J"},{"key":"5990_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/asj\/sjaa339","author":"A Swift","year":"2021","unstructured":"Swift A, Liew S, Weinkle S, Garcia JK, Silberberg MB. The facial aging process from the \u2018inside out.\u2019 Aesthetic Surg J. 2021. https:\/\/doi.org\/10.1093\/asj\/sjaa339.","journal-title":"Aesthetic Surg J"},{"key":"5990_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bjps.2023.04.057","volume":"81","author":"JQ Tay","year":"2023","unstructured":"Tay JQ. Ozempic face: a new challenge for facial plastic surgeons. J Plast Reconstr Aesthet Surg. 2023;81:97\u20138. https:\/\/doi.org\/10.1016\/j.bjps.2023.04.057.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"6","key":"5990_CR15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1055\/a-2148-6321","volume":"39","author":"CD Humphrey","year":"2023","unstructured":"Humphrey CD, Lawrence AC. Implications of ozempic and other semaglutide medications for facial plastic surgeons. Facial Plast Surg. 2023;39(6):719\u201321. https:\/\/doi.org\/10.1055\/a-2148-6321.","journal-title":"Facial Plast Surg"},{"issue":"6","key":"5990_CR16","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1055\/s-0044-1785450","volume":"39","author":"MB Hansen","year":"2023","unstructured":"Hansen MB, Krogh Pedersen KL, Jia T. Letter to the editor: comment on implications of ozempic and other semaglutide medications for facial plastic surgeons. Facial Plast Surg: FPS. 2023;39(6):e2\u20133. https:\/\/doi.org\/10.1055\/s-0044-1785450.","journal-title":"Facial Plast Surg: FPS"},{"issue":"2","key":"5990_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.29333\/ejgm\/82473","volume":"9","author":"SMA El-Kader","year":"2012","unstructured":"El-Kader SMA, Khalifa DA. Impact of weight loss on psychological well being and biochemical modulation in obese patients: a comparison of two treatment protocols. Eur J Gen Med. 2012;9(2):104\u201310. https:\/\/doi.org\/10.29333\/ejgm\/82473.","journal-title":"Eur J Gen Med"},{"key":"5990_CR18","doi-asserted-by":"publisher","DOI":"10.17712\/nsj.2024.4.20230112","author":"AB Alasiri","year":"2024","unstructured":"Alasiri AB, Alahmari FS, Alanazi SD, Alhnake AW, Alkahtani AH, Aljaffer MA. Psychological changes among weight loss injection users compared with bariatric surgery patients in Saudi Arabia. Neurosciences (Riyadh, Saudi Arabia). 2024. https:\/\/doi.org\/10.17712\/nsj.2024.4.20230112.","journal-title":"Neurosciences (Riyadh, Saudi Arabia)"},{"issue":"11","key":"5990_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11934-023-01180-7","volume":"24","author":"MA Moyad","year":"2023","unstructured":"Moyad MA. Embracing the pros and cons of the new weight loss medications (semaglutide, tirzepatide, etc.). Curr Urol Rep. 2023;24(11):515\u201325. https:\/\/doi.org\/10.1007\/s11934-023-01180-7.","journal-title":"Curr Urol Rep"},{"key":"5990_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurpra.2024.105207","author":"S Harding","year":"2024","unstructured":"Harding S. Mental health implications of weight loss medications: a narrative review. J Nurse Pract. 2024. https:\/\/doi.org\/10.1016\/j.nurpra.2024.105207.","journal-title":"J Nurse Pract"},{"issue":"12","key":"5990_CR21","doi-asserted-by":"publisher","first-page":"e70584","DOI":"10.1111\/jocd.70584","volume":"24","author":"IL Kruglikov","year":"2025","unstructured":"Kruglikov IL. Mechanisms of glucagon-like peptide 1 receptor agonist-induced facial lipodystrophy and a path toward prevention. J Cosmet Dermatol. 2025;24(12):e70584. https:\/\/doi.org\/10.1111\/jocd.70584.","journal-title":"J Cosmet Dermatol"},{"key":"5990_CR22","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1298783","author":"K Tansavatdi","year":"2011","unstructured":"Tansavatdi K, Mangat DS. Calcium hydroxyapatite fillers. Facial Plast Surg. 2011. https:\/\/doi.org\/10.1055\/s-0031-1298783.","journal-title":"Facial Plast Surg"},{"issue":"1","key":"5990_CR23","first-page":"38","volume":"8","author":"JV Loghem","year":"2015","unstructured":"Loghem JV, Yutskovskaya YA, Philip Werschler W. Calcium hydroxylapatite: over a decade of clinical experience. J Clin Aesthet Dermatol. 2015;8(1):38\u201349.","journal-title":"J Clin Aesthet Dermatol"},{"key":"5990_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/archfaci.10.5.335","author":"AM Holzapfel","year":"2008","unstructured":"Holzapfel AM, Mangat DS, Barron DS. Soft-tissue augmentation with calcium hydroxylapatite. Histological analysis. Arch Facial Plast Surg. 2008. https:\/\/doi.org\/10.1001\/archfaci.10.5.335.","journal-title":"Arch Facial Plast Surg"},{"key":"5990_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13952","author":"A Koren","year":"2019","unstructured":"Koren A, Isman G, Cohen S, Bar Ilan E, Salameh F, Sprecher E, et al. Efficacy of a combination of diluted calcium hydroxylapatite-based filler and an energy-based device for the treatment of facial atrophic acne scars. Clin Exp Dermatol. 2019. https:\/\/doi.org\/10.1111\/ced.13952.","journal-title":"Clin Exp Dermatol"},{"key":"5990_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/asj\/sjy011","author":"ZP Lorenc","year":"2018","unstructured":"Lorenc ZP, Bass LM, Fitzgerald R, Goldberg DJ, Graivier MH. Physiochemical characteristics of calcium hydroxylapatite (CaHA). Aesthet Surg J. 2018. https:\/\/doi.org\/10.1093\/asj\/sjy011.","journal-title":"Aesthet Surg J"},{"key":"5990_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/9781119676881.ch46","author":"S Mandy","year":"2022","unstructured":"Mandy S. Calcium hydroxylapatite for soft tissue augmentation. Cosmet Dermatol: Prod Proced. 2022. https:\/\/doi.org\/10.1002\/9781119676881.ch46.","journal-title":"Cosmet Dermatol: Prod Proced"},{"issue":"1","key":"5990_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/CIA.S2065","volume":"3","author":"PF Jacoveila","year":"2008","unstructured":"Jacoveila PF. Use of calcium hydroxylapatite (Radiesse\u00ae) for facial augmentation. Clin Interv Aging. 2008;3(1):161\u201374.","journal-title":"Clin Interv Aging"},{"key":"5990_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2022.07.091","author":"S Halepas","year":"2022","unstructured":"Halepas S, Christiansen C, Ferneini EM. Diluted and hyperdiluted calcium hydroxylapatite for skin tightening. J Oral Maxillofac Surg. 2022. https:\/\/doi.org\/10.1016\/j.joms.2022.07.091.","journal-title":"J Oral Maxillofac Surg"},{"issue":"9","key":"5990_CR30","first-page":"996","volume":"12","author":"T Pavicic","year":"2013","unstructured":"Pavicic T. Calcium hydroxylapatite filler: an overview of safety and tolerability. J Drugs Dermatol. 2013;12(9):996\u20131002.","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"5990_CR31","doi-asserted-by":"publisher","first-page":"e14716","DOI":"10.1111\/dth.14716","volume":"34","author":"I Yanatma","year":"2021","unstructured":"Yanatma I, Sarac G, Gul M, Gul S, Kapicioglu Y. Comparison of polycaprolactone and calcium hydroxylapatite dermal fillers in a rat model. Dermatol Therapy. 2021;34(1):e14716. https:\/\/doi.org\/10.1111\/dth.14716.","journal-title":"Dermatol Therapy"},{"key":"5990_CR32","doi-asserted-by":"publisher","DOI":"10.1177\/07488068211016135","author":"J Kadouch","year":"2022","unstructured":"Kadouch J, Fakih-Gomez N. A Hybrid filler: combining calcium hydroxylapatite and hyaluronic acid fillers for aesthetic indications. Am J Cosmet Surg. 2022. https:\/\/doi.org\/10.1177\/07488068211016135.","journal-title":"Am J Cosmet Surg"},{"issue":"1","key":"5990_CR33","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1097\/SCS.0000000000005809","volume":"31","author":"JW Chang","year":"2020","unstructured":"Chang JW, Koo WY, Kim E-K, Lee SW, Lee JH. Facial rejuvenation using a mixture of calcium hydroxylapatite filler and hyaluronic acid filler. J Craniofac Surg. 2020;31(1):e18\u201321. https:\/\/doi.org\/10.1097\/SCS.0000000000005809.","journal-title":"J Craniofac Surg"},{"issue":"10","key":"5990_CR34","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/asj\/sjad173","volume":"43","author":"SB Aguilera","year":"2023","unstructured":"Aguilera SB, McCarthy A, Khalifian S, Lorenc ZP, Goldie K, Chernoff WG. The role of calcium hydroxylapatite (radiesse) as a regenerative aesthetic treatment: a narrative review. Aesthet Surg J. 2023;43(10):1063\u201390. https:\/\/doi.org\/10.1093\/asj\/sjad173.","journal-title":"Aesthet Surg J"},{"key":"5990_CR35","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S407561","author":"ART de Almeida","year":"2023","unstructured":"de Almeida ART, Marques ERMC, Contin LA, de Almeida CT, Muniz M. Efficacy and tolerability of hyperdiluted calcium hydroxylapatite (radiesse) for neck rejuvenation: clinical and ultrasonographic assessment. Clin Cosmet Investig Dermatol. 2023. https:\/\/doi.org\/10.2147\/CCID.S407561.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"5990_CR36","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.7729","author":"S Fabi","year":"2024","unstructured":"Fabi S, Hamilton T, LaTowsky B, Kazin R, Marcus K, Mayoral F, et al. Effectiveness and safety of sculptra poly-l-lactic acid injectable implant in the correction of cheek wrinkles. J Drugs Dermatol. 2024. https:\/\/doi.org\/10.36849\/JDD.7729.","journal-title":"J Drugs Dermatol"},{"key":"5990_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-023-03600-y","author":"WY Han","year":"2023","unstructured":"Han WY, Kim HJ, Kwon R, Kang SM, Yon DK. Safety and efficacy of poly-l-lactic acid filler (Gana V vs. Sculptra) injection for correction of the nasolabial fold: a double-blind, non-inferiority, randomized, split-face controlled trial. Aesthet Plast Surg. 2023. https:\/\/doi.org\/10.1007\/s00266-023-03600-y.","journal-title":"Aesthet Plast Surg"},{"issue":"8","key":"5990_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.12968\/joan.2023.12.Sup8.S6","volume":"12","author":"A Mills","year":"2023","unstructured":"Mills A, Haq S. HArmonyCa: a first-in-class, hybrid, dual-functioning hyaluronic acid\/calcium hydroxyapatite dermal filler. J Aesthet Nurs. 2023;12(8):6\u201312.","journal-title":"J Aesthet Nurs"},{"issue":"23","key":"5990_CR39","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1007\/s00266-023-03649-9","volume":"48","author":"M Barone","year":"2024","unstructured":"Barone M, Salzillo R, Persichetti P. Minimally invasive facial rejuvenation with the hybrid filler HArmonyCaTM. Aesthet Plast Surg. 2024;48(23):5251\u20133. https:\/\/doi.org\/10.1007\/s00266-023-03649-9.","journal-title":"Aesthet Plast Surg"},{"issue":"12","key":"5990_CR40","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1111\/jocd.16503","volume":"23","author":"I Proietti","year":"2024","unstructured":"Proietti I, Spagnoli A, Favaroni A, Gritti A, Dal Canton M, Quartucci S, et al. HArmonyCaTM hybrid filler to restore connective tissue: an italian real-life retrospective study. J Cosmet Dermatol. 2024;23(12):3883\u201392. https:\/\/doi.org\/10.1111\/jocd.16503.","journal-title":"J Cosmet Dermatol"},{"issue":"8","key":"5990_CR41","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1111\/jocd.15706","volume":"22","author":"F Urdiales-G\u00e1lvez","year":"2023","unstructured":"Urdiales-G\u00e1lvez F, Braz A, Cavallini M. Facial rejuvenation with the new hybrid filler HArmonyCaTM: clinical and aesthetic outcomes assessed by 2D and 3D photographs, ultrasound, and elastography. J Cosmet Dermatol. 2023;22(8):2186\u201397. https:\/\/doi.org\/10.1111\/jocd.15706.","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"5990_CR42","doi-asserted-by":"publisher","first-page":"e1743","DOI":"10.1002\/hsr2.1743","volume":"7","author":"A Sparavigna","year":"2024","unstructured":"Sparavigna A, Grimolizzi F, Cigni C, Lualdi R, Bellia G. efficacy and tolerability of Profhilo\u00ae structura intended to restore lateral cheek fat compartment: an observational pilot study. Health Sci Rep. 2024;7(1):e1743. https:\/\/doi.org\/10.1002\/hsr2.1743.","journal-title":"Health Sci Rep"},{"key":"5990_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2147\/CCID.S30794","volume":"5","author":"C Muhn","year":"2012","unstructured":"Muhn C, Rosen N, Solish N, Bertucci V, Lupin M, Dansereau A, et al. The evolving role of hyaluronic acid fillers for facial volume restoration and contouring: a canadian overview. Clin Cosmet Invest Dermatol. 2012;5:147\u201358. https:\/\/doi.org\/10.2147\/CCID.S30794.","journal-title":"Clin Cosmet Invest Dermatol"},{"issue":"4","key":"5990_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2530\/jslsm.jslsm-40_0050","volume":"40","author":"T Nishimura","year":"2020","unstructured":"Nishimura T, Shimojo Y, Hazama H, Awazu K. A method of computational clinical trial of a nanosecond pulsed laser skin treatment device by numerical simulation of photothermal damage. Nippon Laser Igakkaishi. 2020;40(4):301\u20138. https:\/\/doi.org\/10.2530\/jslsm.jslsm-40_0050.","journal-title":"Nippon Laser Igakkaishi"},{"issue":"3","key":"5990_CR45","doi-asserted-by":"publisher","first-page":"032004","DOI":"10.1088\/2516-1091\/acdc71","volume":"5","author":"C Rodero","year":"2023","unstructured":"Rodero C, Baptiste TMG, Barrows RK, Keramati H, Sillett CP, Strocchi M, et al. A systematic review of cardiac in-silico clinical trials. Prog Biomed Eng. 2023;5(3):032004. https:\/\/doi.org\/10.1088\/2516-1091\/acdc71.","journal-title":"Prog Biomed Eng"},{"issue":"1","key":"5990_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/biomedicines12010201","volume":"12","author":"P Chunarkar-Patil","year":"2024","unstructured":"Chunarkar-Patil P, Kaleem M, Mishra R, Ray S, Ahmad A, Verma D, et al. Anticancer drug discovery based on natural products: from computational approaches to clinical studies. Biomedicines. 2024;12(1):201. https:\/\/doi.org\/10.3390\/biomedicines12010201.","journal-title":"Biomedicines"},{"issue":"2","key":"5990_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.18203\/2349-3259.ijct20161408","volume":"3","author":"M Viceconti","year":"2016","unstructured":"Viceconti M, Henney A, Morley-Fletcher E. In silico clinical trials: how computer simulation will transform the biomedical industry. Int J Clin Trials. 2016;3(2):37\u201346. https:\/\/doi.org\/10.18203\/2349-3259.ijct20161408.","journal-title":"Int J Clin Trials"},{"key":"5990_CR48","doi-asserted-by":"publisher","first-page":"741170","DOI":"10.3389\/fpsyt.2021.741170","volume":"12","author":"JR Guti\u00e9rrez-Casares","year":"2021","unstructured":"Guti\u00e9rrez-Casares JR, Quintero J, Jorba G, Junet V, Mart\u00ednez V, Pozo-Rubio T, et al. Methods to develop an in silico clinical trial: computational head-to-head comparison of lisdexamfetamine and methylphenidate. Front Psychiatry. 2021;12:741170. https:\/\/doi.org\/10.3389\/fpsyt.2021.741170.","journal-title":"Front Psychiatry"},{"key":"5990_CR49","doi-asserted-by":"publisher","unstructured":"Ars\u00e8ne S, Par\u00e8s Y, Tixier E, Granejon-Noriot S, Martin B, Bruezi\u00e8re L, Couty C, Courcelles E, Kahoul R, Pitrat J, Go N, Monteiro C, Kleine-Schultjann J, Jemai S, Pham E, Boissel J-P, Kulesza A. In silico clinical trials: is it possible?. In: Heifetz A, editor. High performance computing for drug discovery and biomedicine. Methods in Molecular Biology, vol 2716. Humana, New York, NY; 2024. https:\/\/doi.org\/10.1007\/978-1-0716-3449-3_4","DOI":"10.1007\/978-1-0716-3449-3_4"},{"issue":"5","key":"5990_CR50","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1093\/bib\/bby043","volume":"20","author":"F Pappalardo","year":"2019","unstructured":"Pappalardo F, Russo G, Tshinanu FM, Viceconti M. In silico clinical trials: concepts and early adoptions. Brief Bioinform. 2019;20(5):1699\u2013708. https:\/\/doi.org\/10.1093\/bib\/bby043.","journal-title":"Brief Bioinform"},{"issue":"20","key":"5990_CR51","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.jcin.2023.07.022","volume":"16","author":"S Samant","year":"2023","unstructured":"Samant S, Bakhos JJ, Wu W, Zhao S, Kassab GS, Khan B, et al. Artificial intelligence, computational simulations, and extended reality in cardiovascular interventions. JACC: Cardiovasc Interv. 2023;16(20):2479\u201397. https:\/\/doi.org\/10.1016\/j.jcin.2023.07.022.","journal-title":"JACC: Cardiovasc Interv"},{"issue":"12","key":"5990_CR52","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1007\/s10439-021-02787-y","volume":"49","author":"P Favre","year":"2021","unstructured":"Favre P, Maquer G, Henderson A, Hertig D, Ciric D, Bischoff JE. In silico clinical trials in the orthopedic device industry: from fantasy to reality? Annal Biomed Eng. 2021;49(12):3213. https:\/\/doi.org\/10.1007\/s10439-021-02787-y.","journal-title":"Annal Biomed Eng"},{"issue":"13","key":"5990_CR53","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.21608\/ejchem.2024.337877.10835","volume":"67","author":"MQB Ozaybi","year":"2024","unstructured":"Ozaybi MQB, Madkhali ANM, Alhazmi MAM, Faqihi HMA, Alanazi MM, Siraj WHY, et al. The role of artificial intelligence in drug discovery and development. Egypt J Chem. 2024;67(13):1541\u20137. https:\/\/doi.org\/10.21608\/ejchem.2024.337877.10835.","journal-title":"Egypt J Chem"},{"key":"5990_CR54","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.bbcan.2021.188572","volume":"1","author":"L Kolla","year":"1876","unstructured":"Kolla L, Gruber FK, Khalid O, Hill C, Parikh RB. The case for AI-driven cancer clinical trials \u2013 the efficacy arm in silico. Biochim Biophys Acta Rev Cancer. 1876;1:2021. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188572.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"5990_CR55","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00238-025-02331-4","volume":"48","author":"E Rahman","year":"2025","unstructured":"Rahman E, Rao P, Nassif AD, Webb WR, Wu WT, Carruthers JDA. Beyond binary endpoints: modernizing aesthetic trial analytics: simulation-based reappraisal of phase 2\/3 BoNT-A studies using advanced statistical models. Eur J Plast Surg. 2025;48(1):70. https:\/\/doi.org\/10.1007\/s00238-025-02331-4.","journal-title":"Eur J Plast Surg"},{"issue":"1","key":"5990_CR56","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00238-025-02311-8","volume":"48","author":"E Rahman","year":"2025","unstructured":"Rahman E, Peter Peng H-L, Wu WTL, Webb WR. In silico multiscale comparison of letibotulinumtoxina and onabotulinumtoxina in glabellar line treatment: diffusion dynamics, receptor affinity, and immunologic clearance. Eur J Plast Surg. 2025;48(1):52. https:\/\/doi.org\/10.1007\/s00238-025-02311-8.","journal-title":"Eur J Plast Surg"},{"key":"5990_CR57","doi-asserted-by":"publisher","first-page":"108548","DOI":"10.1016\/j.toxicon.2025.108548","volume":"266","author":"E Rahman","year":"2025","unstructured":"Rahman E, Carruthers JDA, Rao P, Ahmed M, Goodman GJ, Webb WR. In silico multiscale computational modelling of botulinum toxin a diffusion for glabellar wrinkle treatment: optimizing injection volumes across formulations. Toxicon. 2025;266:108548. https:\/\/doi.org\/10.1016\/j.toxicon.2025.108548.","journal-title":"Toxicon"},{"issue":"4","key":"5990_CR58","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/toxins17040182","volume":"17","author":"E Rahman","year":"2025","unstructured":"Rahman E, Rao P, Ahmed M, Webb WR, Carruthers JDA. computational immunogenetic analysis of botulinum toxin a immunogenicity and HLA Gene haplotypes: new insights. Toxins. 2025;17(4):182. https:\/\/doi.org\/10.3390\/toxins17040182.","journal-title":"Toxins"},{"key":"5990_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2025.108560","volume":"267","author":"E Rahman","year":"2025","unstructured":"Rahman E, DA Carruthers J, Ahmed M, Flanagan A, Peng H-LP, Goodman GJ, et al. targeting the glabellar frown lines with OnabotulinumtoxinA: In-silico evidence supporting concentrated, low-volume injection protocols. Toxicon. 2025;267:108560. https:\/\/doi.org\/10.1016\/j.toxicon.2025.108560.","journal-title":"Toxicon"},{"key":"5990_CR60","doi-asserted-by":"publisher","first-page":"108928","DOI":"10.1016\/j.toxicon.2025.108928","volume":"270","author":"E Rahman","year":"2025","unstructured":"Rahman E, Michon A, Rao P, Ahmed M, Wu WTL, Joseph JH, et al. If accessory proteins dissociate, why don\u2019t toxins behave the same? Multiscale simulation shows divergent in silico profiles despite an identical core neurotoxin. Toxicon. 2025;270:108928. https:\/\/doi.org\/10.1016\/j.toxicon.2025.108928.","journal-title":"Toxicon"},{"key":"5990_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2025.108665","volume":"269","author":"E Rahman","year":"2026","unstructured":"Rahman E, Michon A, Rao P, Ahmed M, Joseph JH, Wu WTL, et al. Computational model-informed comparative evaluation of botulinum toxin a formulations: A 20-year simulation of onset, diffusion, duration, and immunogenicity. Toxicon. 2026;269:108665. https:\/\/doi.org\/10.1016\/j.toxicon.2025.108665.","journal-title":"Toxicon"},{"key":"5990_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2025.108946","volume":"271","author":"E Rahman","year":"2026","unstructured":"Rahman E, Michon A, Rao P, Joseph JH, Wu WTL, Webb WR. Beyond structural divergence: multiscale computational immunogenicity modelling of botulinum neurotoxin e and cross-reactivity in botulinum neurotoxin a primed hosts. Toxicon. 2026;271:108946. https:\/\/doi.org\/10.1016\/j.toxicon.2025.108946.","journal-title":"Toxicon"},{"issue":"3","key":"5990_CR63","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s12020-021-02945-1","volume":"75","author":"P Zhong","year":"2022","unstructured":"Zhong P, Zeng H, Huang M, Fu W, Chen Z. Efficacy and safety of once-weekly semaglutide in adults with overweight or obesity: A meta-analysis. Endocrine. 2022;75(3):718\u201324. https:\/\/doi.org\/10.1007\/s12020-021-02945-1.","journal-title":"Endocrine"},{"issue":"3","key":"5990_CR64","doi-asserted-by":"publisher","first-page":"A4365415","DOI":"10.1161\/circ.152.suppl_3.4365415","volume":"152","author":"A Moiz","year":"2025","unstructured":"Moiz A, Filion K, Reynier P, Lelievre A, Toutounchi H, Tsoukas M, et al. Abstract 4365415: comparative efficacy of glucagon-like peptide-1 receptor agonists and co-agonists for weight loss among patients without diabetes: a network meta-analysis. Circulation. 2025;152(3):A4365415\u2013A4365415. https:\/\/doi.org\/10.1161\/circ.152.suppl_3.4365415.","journal-title":"Circulation"},{"key":"5990_CR65","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S470826","author":"XD Yang","year":"2024","unstructured":"Yang XD, Yang YY. Clinical pharmacokinetics of semaglutide: a systematic review. Drug Des Dev Ther. 2024. https:\/\/doi.org\/10.2147\/DDDT.S470826.","journal-title":"Drug Des Dev Ther"},{"key":"5990_CR66","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e31829d1d40","author":"H Sundaram","year":"2013","unstructured":"Sundaram H, Cassuto D. Biophysical characteristics of hyaluronic acid soft-tissue fillers and their relevance to aesthetic applications. Plast Reconstr Surg. 2013. https:\/\/doi.org\/10.1097\/PRS.0b013e31829d1d40.","journal-title":"Plast Reconstr Surg"},{"key":"5990_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2008.01046.x","author":"J Kablik","year":"2009","unstructured":"Kablik J, Monheit GD, Yu LP, Chang G, Gershkovich J. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg. 2009. https:\/\/doi.org\/10.1111\/j.1524-4725.2008.01046.x.","journal-title":"Dermatol Surg"},{"issue":"1","key":"5990_CR68","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00403-024-03567-z","volume":"317","author":"A Elrosasy","year":"2024","unstructured":"Elrosasy A, Abo Zeid M, Hindawi MD, Cadri S, Ismeal AAA, Eldeeb HA, et al. Efficacy and safety of different hyaluronic acid fillers on cheek volume augmentation: Systematic review and network meta-analysis. Archiv Dermatol Res. 2024;317(1):152. https:\/\/doi.org\/10.1007\/s00403-024-03567-z.","journal-title":"Archiv Dermatol Res"},{"key":"5990_CR69","doi-asserted-by":"publisher","first-page":"1195934","DOI":"10.3389\/fmed.2023.1195934","volume":"10","author":"M Amiri","year":"2023","unstructured":"Amiri M, Me\u00e7ani R, Niehot CD, Phillips T, Kolb J, Daughtry H, et al. Skin regeneration-related mechanisms of calcium hydroxylapatite (CaHA): A systematic review. Front Med. 2023;10:1195934. https:\/\/doi.org\/10.3389\/fmed.2023.1195934.","journal-title":"Front Med"},{"key":"5990_CR70","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S420068","author":"E Massidda","year":"2023","unstructured":"Massidda E. Starting point for protocols on the use of hyperdiluted calcium hydroxylapatite (Radiesse\u00ae) for optimizing age-related biostimulation and rejuvenation of face, neck, d\u00e9colletage and hands: a case series report. Clin Cosmet Investig Dermatol. 2023. https:\/\/doi.org\/10.2147\/CCID.S420068.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"5990_CR71","doi-asserted-by":"publisher","DOI":"10.1097\/PSN.0000000000000571","author":"R Forte","year":"2024","unstructured":"Forte R, Salti G, Tateo A. Profhilo\u00ae structura, current status and future perspectives: a practical review. Plast Aesthet Nurs. 2024. https:\/\/doi.org\/10.1097\/PSN.0000000000000571.","journal-title":"Plast Aesthet Nurs"},{"issue":"1","key":"5990_CR72","doi-asserted-by":"publisher","first-page":"8159047","DOI":"10.1155\/2020\/8159047","volume":"2020","author":"D Cassuto","year":"2020","unstructured":"Cassuto D, Delledonne M, Zaccaria G, Illiano I, Giori AM, Bellia G. Safety assessment of high- and low-molecular-weight hyaluronans (Profhilo\u00ae) as derived from worldwide postmarketing data. BioMed Res Int. 2020;2020(1):8159047. https:\/\/doi.org\/10.1155\/2020\/8159047.","journal-title":"BioMed Res Int"},{"issue":"10","key":"5990_CR73","doi-asserted-by":"publisher","first-page":"628","DOI":"10.23736\/S0393-3660.23.05199-9","volume":"182","author":"A Sparavigna","year":"2023","unstructured":"Sparavigna A, Cigni C, Grimolizzi F, Bellia G. Neck and face rejuvenation outcomes with Profhilo\u00ae: A comparative analysis between chinese and caucasian cohorts. Gazzetta Medica Italiana Archivio per le Scienze Mediche. 2023;182(10):628\u201333. https:\/\/doi.org\/10.23736\/S0393-3660.23.05199-9.","journal-title":"Gazzetta Medica Italiana Archivio per le Scienze Mediche"},{"issue":"1","key":"5990_CR74","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jdermsci.2015.01.012","volume":"78","author":"P Stein","year":"2015","unstructured":"Stein P, Vitavska O, Kind P, Hoppe W, Wieczorek H, Sch\u00fcrer NY. The biological basis for poly-l-lactic acid-induced augmentation. J Dermatol Sci. 2015;78(1):26\u201333. https:\/\/doi.org\/10.1016\/j.jdermsci.2015.01.012.","journal-title":"J Dermatol Sci"},{"key":"5990_CR75","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-025-05030-4","author":"LET Avelar","year":"2025","unstructured":"Avelar LET, Yan X, Br\u00e5s\u00e4ter D. Comprehensive systematic review of poly-l-lactic acid in facial clinical application. Aesthet Plast Surg. 2025. https:\/\/doi.org\/10.1007\/s00266-025-05030-4.","journal-title":"Aesthet Plast Surg"},{"key":"5990_CR76","doi-asserted-by":"publisher","DOI":"10.4161\/derm.22804","author":"R Ganceviciene","year":"2012","unstructured":"Ganceviciene R, Liakou AI, Theodoridis A, Makrantonaki E, Zouboulis CC. Skin anti-aging strategies. Dermato-Endocrinol. 2012. https:\/\/doi.org\/10.4161\/derm.22804.","journal-title":"Dermato-Endocrinol"},{"key":"5990_CR77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2494.2007.00415.x","author":"MA Farage","year":"2007","unstructured":"Farage MA, Miller KW, Elsner P, Maibach HI. Intrinsic and extrinsic factors in skin ageing: A review. Int J Cosmet Sci. 2007. https:\/\/doi.org\/10.1111\/j.1468-2494.2007.00415.x.","journal-title":"Int J Cosmet Sci"},{"key":"5990_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/minf.201400137","author":"PN Judson","year":"2015","unstructured":"Judson PN, Barber C, Canipa SJ, Poignant G, Williams R. Establishing good computer modelling practice (GCMP) in the prediction of chemical toxicity. Mol Inform. 2015. https:\/\/doi.org\/10.1002\/minf.201400137.","journal-title":"Mol Inform"},{"key":"5990_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-022-01710-x","author":"M Barker","year":"2022","unstructured":"Barker M, Chue Hong NP, Katz DS, Lamprecht AL, Martinez-Ortiz C, Psomopoulos F, et al. Introducing the FAIR principles for research software. Sci Data. 2022. https:\/\/doi.org\/10.1038\/s41597-022-01710-x.","journal-title":"Sci Data"},{"key":"5990_CR80","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e3182910a57","author":"CH Wong","year":"2013","unstructured":"Wong CH, Mendelson B. Facial soft-tissue spaces and retaining ligaments of the midcheek: defining the premaxillary space. Plast Reconstr Surg. 2013. https:\/\/doi.org\/10.1097\/PRS.0b013e3182910a57.","journal-title":"Plast Reconstr Surg"},{"key":"5990_CR81","doi-asserted-by":"publisher","DOI":"10.1093\/asjof\/ojae069","volume":"6","author":"AB Jafar","year":"2024","unstructured":"Jafar AB, Jacob J, Kao WK, Ho T. Soft tissue facial changes following massive weight loss secondary to medical and surgical bariatric interventions: A systematic review. Aesthet Surg J Open Forum. 2024;6:ojae069. https:\/\/doi.org\/10.1093\/asjof\/ojae069.","journal-title":"Aesthet Surg J Open Forum"},{"key":"5990_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61101823","author":"A Safia","year":"2025","unstructured":"Safia A, Abd Elhadi U, Merchavy S, Batheesh R, Bathish N. Efficacy and safety of hyaluronic acid fillers for midface augmentation: a systematic review and meta-analysis. Medicina (B Aires). 2025. https:\/\/doi.org\/10.3390\/medicina61101823.","journal-title":"Medicina (B Aires)"},{"key":"5990_CR83","doi-asserted-by":"publisher","unstructured":"Mazzuci R, Dal'Forno T, Alfonso Dini S. Subcutaneous versus supraperiosteal injections of poly-L-lactic acid: a clinical and imaging study. Dermatol Surg. 2021;47(5):743\u2013745. https:\/\/doi.org\/10.1097\/DSS.0000000000002614","DOI":"10.1097\/DSS.0000000000002614"},{"key":"5990_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/polym16182564","author":"R Signori","year":"2024","unstructured":"Signori R, Barbosa AdeP, Cezar-dos-Santos F, Carbone AC, Ventura S, Nobre BBdeS, et al. Efficacy and safety of poly-l-lactic acid in facial aesthetics: A systematic review. Polymers (Basel). 2024. https:\/\/doi.org\/10.3390\/polym16182564.","journal-title":"Polymers (Basel)"},{"key":"5990_CR85","doi-asserted-by":"publisher","DOI":"10.2147\/ccid.s385202","author":"M Angelo-Khattar","year":"2022","unstructured":"Angelo-Khattar M. Objective assessment of the long-term volumizing action of a polycaprolactone-based filler. Clin Cosmet Investig Dermatol. 2022. https:\/\/doi.org\/10.2147\/ccid.s385202.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"5990_CR86","doi-asserted-by":"publisher","unstructured":"Durairaj KK, McCarthy AD, Yambao M, Linnemann-Heath J. Hyperdilute radiesse preserves facial volume in glucagon-like peptide-1 receptor agonist users undergoing rapid weight loss. Aesthet Surg J Open Forum. 2025;7:ojaf088. https:\/\/doi.org\/10.1093\/asjof\/ojaf088","DOI":"10.1093\/asjof\/ojaf088"},{"key":"5990_CR87","doi-asserted-by":"publisher","unstructured":"Chu J, Zhang H, Wu Y, Huang Y, Zhu T, Zhou Z, Wang H. Efficacy of lifestyle modification combined with GLP-1 receptor agonists on body weight and cardiometabolic biomarkers in individuals with overweight or obesity: a systematic review and meta-analysis. eClinical Medicine. 2025;88:103464. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103464","DOI":"10.1016\/j.eclinm.2025.103464"},{"issue":"12","key":"5990_CR88","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1093\/gerona\/glab068","volume":"76","author":"AA Weaver","year":"2021","unstructured":"Weaver AA, Tooze JA, Cauley JA, Bauer DC, Tylavsky FA, Kritchevsky SB, et al. Effect of dietary protein intake on bone mineral density and fracture incidence in older adults in the health, aging, and body composition study. J Gerontol - Series A Biol Sci Med Sci. 2021;76(12):2213\u201322. https:\/\/doi.org\/10.1093\/gerona\/glab068.","journal-title":"J Gerontol - Series A Biol Sci Med Sci"},{"issue":"1","key":"5990_CR89","first-page":"62","volume":"19","author":"DR Mest","year":"2006","unstructured":"Mest DR, Humble G. Human immunodeficiency virus-associated facial lipoatrophy: a review. Cosmet Dermatol. 2006;19(1):62\u20136.","journal-title":"Cosmet Dermatol"},{"issue":"3","key":"5990_CR90","first-page":"9399","volume":"13","author":"FG Bechara","year":"2008","unstructured":"Bechara FG, Sand M, Potthoff A, Altmeyer P, Brockmeyer NH. HIV-associated facial lipoatrophy - review of current therapy options. Eur J Med Res. 2008;13(3):9399.","journal-title":"Eur J Med Res"},{"issue":"3","key":"5990_CR91","doi-asserted-by":"publisher","first-page":"34S","DOI":"10.1097\/01.prs.0000234847.36020.52","volume":"118","author":"SL Silvers","year":"2006","unstructured":"Silvers SL, Eviatar JA, Echavez MI, Pappas AL. prospective, open-label, 18-month trial of calcium hydroxylapatite (radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability. Plast Reconst Surg. 2006;118(3):34S-45S. https:\/\/doi.org\/10.1097\/01.prs.0000234847.36020.52.","journal-title":"Plast Reconst Surg"},{"issue":"2","key":"5990_CR92","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1468-1293.2004.00190.x","volume":"5","author":"GJ Moyle","year":"2004","unstructured":"Moyle GJ, Lysakova L, Brown S, Sibtain N, Healy J, Priest C, et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med. 2004;5(2):82\u20137. https:\/\/doi.org\/10.1111\/j.1468-1293.2004.00190.x.","journal-title":"HIV Med"},{"issue":"2","key":"5990_CR93","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/cpt.3245","volume":"116","author":"GR Galluppi","year":"2024","unstructured":"Galluppi GR, Ahamadi M, Bhattacharya S, Budha N, Gheyas F, Li C, et al. Considerations for industry\u2014preparing for the FDA model-informed drug development (MIDD) paired meeting program. Clin Pharmacol Ther. 2024;116(2):282\u20138. https:\/\/doi.org\/10.1002\/cpt.3245.","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"5990_CR94","doi-asserted-by":"publisher","first-page":"e537","DOI":"10.1038\/s41591-020-1034-x","volume":"2","author":"X Liu","year":"2020","unstructured":"Liu X, Cruz Rivera S, Moher D, Calvert MJ, Denniston AK, Chan AW, et al. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: The CONSORT-AI extension. Nat Med. 2020;2(10):e537\u201348. https:\/\/doi.org\/10.1038\/s41591-020-1034-x.","journal-title":"Nat Med"},{"key":"5990_CR95","unstructured":"Food and Drug Administration (FDA). Assessing the credibility of computational modeling and simulation in medical device submissions. 2021."}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-026-05990-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00266-026-05990-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-026-05990-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:52:15Z","timestamp":1791388335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00266-026-05990-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":95,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5990"],"URL":"https:\/\/doi.org\/10.1007\/s00266-026-05990-1","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr Rao worked as a consultant and speaker for Allergan Aesthetics an AbbVie company (Irvine, CA); Dr Michon is a consultant, and speaker for Allergan Aesthetics an AbbVie Company), consultant for Galderma Canada and SkinCeuticals Canada, L\u2019Or\u00e9al Paris; Dr Joseph is an investigator and advisory board member for Allergan Aesthetics, an AbbVie company (Irvine, CA); clinical investigator for Galderma (Lausanne, Switzerland), Merz (Raleigh, NC), Evolus (Newport Beach, CA), Revance (Newark, CA), and Croma (Leobendorf, Austria); speaker or consultant for Galderma, Merz, and Evolus; advisor for Revance and Croma; and shareholder for Evolus and Revance. Dr Joseph is the Chief Medical Officer for Amalfi-Bio. Dr Wu is a speaker and consultant for Allergan Aesthetics an AbbVie Company, Merz Pharmaceuticals GmbH; Dr Webb is the founder of AesthetiSIM. Dr Rahman, Dr Saklayen and Dr Ahmed have nothing to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Human Rights and Animal Participants","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study, informed consent is not required. However, explicit consent was obtained to use photography for publication.","order":3,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}